DRAWDOWN EQUITY FINANCING
AGREEMENT
THIS AGREEMENT dated as of the 8 th day of April 2009 (the “ Agreement
”) between Auctus Private Equity Fund, LLC a
Massachusetts corporation (the “ Investor
”), and CRC Crystal Research Corporation a corporation
organized and existing under the laws of the State of Nevada (the
“ Company ”).
WHEREAS , the parties desire that, upon the terms and
subject to the conditions contained herein, the Company shall issue
and sell to the Investor, from time to time as provided herein, and
the Investor shall purchase from the Company up to Ten
Million Dollars ($10,000,000) of the
Company’s common stock, par value $0.001 per share (the
“ Common Stock ”); and
WHEREAS , such investments will be made in reliance upon
the provisions of Regulation D (“ Regulation D
”) of the Securities Act of 1933, as amended, and the
regulations promulgated thereunder (the “ Securities
Act ”), and or upon such other exemption from the
registration requirements of the Securities Act as may be available
with respect to any or all of the investments to be made
hereunder.
NOW ,
THEREFORE , the parties hereto agree as follows:
ARTICLE I.
Certain
Definitions
Section 1.1. “ Advance
” shall mean the portion of the Commitment Amount requested
by the Company in the Drawdown Notice.
Section 1.2. “ Advance Date
” shall mean the first (1 st )
Trading Day after expiration of the applicable Pricing Period for
each Advance.
Section 1.3. “ Drawdown
Notice ” shall mean a written notice in the form of
Exhibit A attached hereto to the Investor executed by an
officer of the Company and setting forth the Advance amount that
the Company requests from the Investor.
Section 1.4. “ Drawdown Notice
Date ” shall mean each date the Company delivers (in
accordance with Section 2.2(b) of this Agreement) to the Investor a
Drawdown Notice requiring the Investor to advance funds to the
Company, subject to the terms of this Agreement. No
Drawdown Notice Date shall be less than five (5) Trading Days after
the prior Drawdown Notice Date.
Section 1.5. “ Bid Price
” shall mean, on any date, the closing bid price (as reported
by Bloomberg L.P.) of the Common Stock on the Principal Market or
if the Common Stock is not traded on a Principal Market, the
highest reported bid price for the Common Stock, as furnished by
the National Association of Securities Dealers, Inc.
Section 1.6. “ Closing
” shall mean one of the closings of a purchase and sale of
Common Stock pursuant to Section 2.3.
Section 1.7. “ Commitment
Amount ” shall mean the aggregate amount of up to Ten
Million Dollars ($10,000,000) which the Investor has agreed to
provide to the Company in order to purchase the Company’s
Common Stock pursuant to the terms and conditions of this
Agreement.
Section 1.8. “ Commitment
Period ” shall mean the period commencing on the earlier
to occur of (i) the Effective Date, or (ii) such earlier date as
the Company and the Investor may mutually agree in writing, and
expiring on the earliest to occur of (x) the date on which the
Investor shall have made payment of Advances pursuant to this
Agreement in the aggregate amount of the Commitment Amount, (y) the
date this Agreement is terminated pursuant to Section 10.2 or (z)
the date occurring thirty-six (36) months after the Effective
Date.
Section 1.9. “ Common Stock
” shall mean the Company’s common stock, par value
$0.001 per share.
Section 1.10. “ Condition
Satisfaction Date ” shall have the meaning set forth in
Section 7.2.
Section 1.11. “ Damages
” shall mean any loss, claim, damage, liability, costs and
expenses (including, without limitation, reasonable
attorney’s fees and disbursements and costs and expenses of
expert witnesses and investigation).
Section 1.12. “ Effective
Date ” shall mean the date on which the SEC first
declares effective a Registration Statement registering the resale
of the Registrable Securities as set forth in Section
7.2(a).
Section 1.13. “ Exchange Act
” shall mean the Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder.
Section 1.14. “ Floor ”
shall mean the Investor shall immediately cease selling any shares
within the Drawdown Notice if the price falls below a predetermined
level (“Floor Price”). The Floor Price is defined
as Seventy-Five (75%) of the average closing bid price
of the stock over the preceding ten (10) trading days prior to the
Drawdown Notice Date. Section 1.15.“ Material Adverse
Effect ” shall mean any condition, circumstance, or
situation that would prohibit or otherwise materially interfere
with the ability of the Company to enter into and perform any of
its obligations under this Agreement or the Registration Rights
Agreement in any material respect.
Section 1.16. “ Market Price
” shall mean the lowest closing Bid Price of the Common Stock
during the Pricing Period.
Section 1.17. “ Maximum Advance
Amount ” shall not exceed One Hundred and Fifty Thousand
Dollars ($150,000) or two hundred (200%) percent of the
average daily volume based on the trailing ten (10) days preceding
the Drawdown Notice date whichever is of a larger value.
Section 1.18. “ Person
” shall mean an individual, a corporation, a partnership, an
association, a trust or other entity or organization, including a
government or political subdivision or an agency or instrumentality
thereof.
Section 1.19. “ Pricing
Period ” shall mean the five (5) consecutive Trading Days
after the Drawdown Notice Date.
Section 1.20. “ Principal
Market ” shall mean the Nasdaq National Market, the
Nasdaq Capital Market, the American Stock Exchange, the OTC
Bulletin Board, OTC Pink Sheets or the New York Stock Exchange,
whichever is at the time the principal trading exchange or market
for the Common Stock.
Section 1.21. “ Purchase
Price ” shall be set at Ninety-Three percent
(93%) (a Seven Percent (7%) discount) of the lowest
closing bid price of the common stock during the Pricing
Period.
Section 1.22. “ Registrable
Securities ” shall mean the shares of Common Stock to be
issued hereunder (i) in respect of which the
Registration Statement has not been declared effective by the SEC,
(ii) which have not been sold under circumstances meeting all of
the applicable conditions of Rule 144 (or any similar provision
then in force) under the Securities Act (“ Rule 144
”) or (iii) which have not been otherwise transferred to a
holder who may trade such shares without restriction under the
Securities Act, and the Company has delivered a new certificate or
other evidence of ownership for such securities not bearing a
restrictive legend.
Section 1.23. “ Registration
Rights Agreement ” shall mean the Registration Rights
Agreement dated the date hereof, regarding the filing of the
Registration Statement for the resale of the Registrable
Securities, entered into between the Company and the
Investor.
Section 1.24. “ Registration
Statement ” shall mean a registration statement on Form
S-1 (if use of such form is then available to the
Company pursuant to the rules of the SEC and, if not, on such other
form promulgated by the SEC for which the Company then qualifies
and which counsel for the Company shall deem appropriate, and which
form shall be available for the resale of the Registrable
Securities to be registered thereunder in accordance with the
provisions of this Agreement and the Registration Rights Agreement,
and in accordance with the intended method of distribution of such
securities), for the registration of the resale by the Investor of
the Registrable Securities under the Securities Act.
Section 1.25. “ Regulation D
” shall have the meaning set forth in the recitals of this
Agreement.
Section 1.26. “ SEC ”
shall mean the United States Securities and Exchange
Commission.
Section 1.27. “ Securities
Act ” shall have the meaning set forth in the recitals of
this Agreement.
Section 1.28. “ SEC Documents
” shall mean Annual Reports on Form 10-K, Quarterly Reports
on Form 10-Q, Current Reports on Form 8-K and Proxy Statements of
the Company as supplemented to the date hereof, filed by the
Company for a period of at least twelve (12) months immediately
preceding the date hereof or the Advance Date, as the case may be,
until such time as the Company no longer has an obligation to
maintain the effectiveness of a Registration Statement as set forth
in the Registration Rights Agreement.
Section 1.30. “ Trading Day
” shall mean any day during which the New York Stock Exchange
shall be open for business.
ARTICLE II.
Advances
Subject to the terms and conditions of this
Agreement (including, without limitation, the provisions of Article
VII hereof), the Company, at its sole and exclusive option, may
issue and sell to the Investor, and the Investor shall purchase
from the Company, shares of the Company’s Common Stock by the
delivery, in the Company’s sole discretion, of Drawdown
Notices. The number of shares of Common Stock that the
Investor shall purchase pursuant to each Advance shall be
determined by dividing the amount of the Advance by the Purchase
Price. No fractional shares shall be issued. Fractional
shares shall be rounded to the next higher whole number of
shares. The aggregate maximum amount of all Advances
that the Investor shall be obligated to make under this Agreement
shall not exceed the Commitment Amount.
(a)
Drawdown Notice . At any time during the
Commitment Period, the Company may request the Investor to purchase
shares of Common Stock by delivering a Drawdown Notice to the
Investor, subject to the conditions set forth in Section 7.2;
provided, however, the amount for each Advance as designated by the
Company in the applicable Drawdown Notice shall not be more than
the Maximum Advance Amount and the aggregate amount of the Advances
pursuant to this Agreement shall not exceed the Commitment
Amount. The Company acknowledges that the Investor may
sell shares of the Company’s Common Stock corresponding with
a particular Drawdown Notice after the Drawdown Notice is received
by the Investor. There shall be a minimum of five (5)
Trading Days between each Drawdown Notice Date.
(b)
Date of Delivery of Drawdown Notice . A Drawdown
Notice shall be deemed delivered on (i) the Trading Day it is
received by email to at louposner@auctusfund.com and
als@auctusfund.com . If such notice is received prior to 5:00 pm
Eastern Time, or (ii) the immediately succeeding Trading Day if it
is received by facsimile or otherwise after 5:00 pm Eastern Time on
a Trading Day or at any time on a day which is not a Trading
Day. No Drawdown Notice may be deemed delivered on a day
that is not a Trading Day or if positive receipt is not
acknowledged by Auctus.
Section 2.3. Closings
. On each Advance Date (i) the Company shall deliver to
the Investor such number of shares of the Common Stock registered
in the name of the Investor as shall equal (x) the amount of the
Advance specified in such Drawdown Notice pursuant to Section 2.1
herein, divided by (y) the Purchase Price and (ii) upon receipt of
such shares, the Investor shall deliver to the Company the amount
of the Advance specified in the Drawdown Notice by wire transfer of
immediately available funds. In addition, on or prior to
the Advance Date, each of the Company and the Investor shall
deliver to the other all documents, instruments and writings
required to be delivered by either of them pursuant to this
Agreement in order to implement and effect the transactions
contemplated herein. To the extent the Company has not
paid the fees, expenses, and disbursements of the Investor in
accordance with Section 12.4, the amount of such fees, expenses,
and disbursements may be deducted by the Investor (and shall be
paid to the relevant party) directly out of the proceeds of the
Advance with no reduction in the amount of shares of the
Company’s Common Stock to be delivered on such Advance
Date.
(a)
Company’s Obligations Upon Closing .
(i) The
Company shall deliver to the Investor, through the use of a
Deposit/Withdrawal at Custodian from a Deposit Trust Company method
or commonly referred to as “DWAC/CTC” of the
Investor’s choosing, the shares of Common Stock applicable to
the Advance in accordance with Section 2.3. The
certificates evidencing such shares shall be free of restrictive
legends. Upon receipt, Investor will perform a wire
transfer on the same business day provided that the shares have
been received in sufficient time to perform such
transfer. In the event that the Investor is no longer
able, due to time constraints beyond his control, to perform a wire
on the day of receipt, the wire will be promptly executed the
following business day.
(ii)
the Company’s Registration Statement with respect
to the resale of the shares of Common Stock delivered in connection
with the Advance shall have been declared effective by the
SEC;
(iii) the
Company shall have obtained all material permits and qualifications
required by any applicable state for the offer and sale of the
Registrable Securities, or shall have the availability of
exemptions therefrom. The sale and issuance of the
Registrable Securities shall be legally permitted by all laws and
regulations to which the Company is subject;
(iv) the
Company shall have filed with the SEC in a timely manner all
reports, notices and other documents required of a “reporting
company” under the Exchange Act and applicable Commission
regulations;
(v)
the fees as set forth in Section 12.4 below shall have
been paid or can be withheld as provided in Section 2.3;
and
(vi) The
Company’s transfer agent shall be DWAC eligible.
(b)
Investor’s Obligations Upon Closing . Upon
receipt of the shares referenced in Section 2.3(a)(i) above and
provided the Company is in compliance with its obligations in
Section 2.3, the Investor shall deliver to the Company the amount
of the Advance specified in the Drawdown Notice by wire transfer of
immediately available funds.
Section
2.4. Hardship . In the event the Investor
sells shares of the Company’s Common Stock after receipt of
an Drawdown Notice and the Company fails to perform its obligations
as mandated in Section 2.3, and specifically the Company fails to
deliver to the Investor on the Advance Date the shares of Common
Stock corresponding to the applicable Advance pursuant to Section
2.3(a)(i), the Company acknowledges that the Investor shall suffer
financial hardship and therefore shall be liable for any and all
losses, commissions, fees, interest, legal fees or any other
financial hardship caused to the Investor.
The Company
understands that a delay in the delivery of the securities in the
form required pursuant to this registration statement beyond the
Closing could result in economic loss to the
Investor. After the Effective Date, as compensation to
the Investor for late issuance of such shares (delivery of
securities after the applicable closing), the Company agrees to
make payments to the Investor in accordance with the schedule below
where the number of days overdue is defined as the number of
business days beyond the close with amount due being
cumulative.
The Company
shall pay any payments incurred under this Section in immediately
available funds upon demand. Nothing herein shall limit
the right of the Investor to pursue damages for the Company’s
failure to comply with the issuance and delivery of securities to
the Investor.
Payments for
Each Number of Days Overdue
|
$10,000 Worth
of Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$1000 + $200
for each Business Day beyond the tenth day
|
ARTICLE III.
Representations and Warranties of
Investor
Investor hereby represents and warrants to, and
agrees with, the Company that the following are true and correct as
of the date hereof and as of each Advance Date:
Section 3.1. Organization and
Authorization . The Investor is duly incorporated or
organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite power and
authority to purchase and hold the securities issuable
hereunder. The decision to invest and the execution and
delivery of this Agreement by such Investor, the performance by
such Investor of its obligations hereunder and the consummation by
such Investor of the transactions contemplated hereby have been
duly authorized and requires no other proceedings on the part of
the Investor. The undersigned has the right, power and
authority to execute and deliver this Agreement and all other
instruments (including, without limitations, the Registration
Rights Agreement), on behalf of the Investor. This
Agreement has been duly executed and delivered by the Investor and,
assuming the execution and delivery hereof and acceptance thereof
by the Company, will constitute the legal, valid and binding
obligations of the Investor, enforceable against the Investor in
accordance with its terms.
Section 3.2. Evaluation of Risks
. The Investor has such knowledge and experience in
financial, tax and business matters as to be capable of evaluating
the merits and risks of, and bearing the economic risks entailed
by, an investment in the Company and of protecting its interests in
connection with this transaction. It recognizes that its
investment in the Company involves a high degree of
risk.
Section 3.3. No Legal Advice From the
Company . The Investor acknowledges that it had the
opportunity to review this Agreement and the transactions
contemplated by this Agreement with his or its own legal counsel
and investment and tax advisors. The Investor is relying
solely on such counsel and advisors and not on any statements or
representations of the Company or any of its representatives or
agents for legal, tax or investment advice with respect to this
investment, the transactions contemplated by this Agreement or the
securities laws of any jurisdiction.
Section 3.4. Investment Purpose .
The securities are being purchased by the Investor for its own
account, and for investment purposes. The Investor
agrees not to assign or in any way transfer the Investor’s
rights to the securities or any interest therein and acknowledges
that the Company will not recognize any purported assignment or
transfer except in accordance with applicable Federal and state
securities laws. No other person has or will have a
direct or indirect beneficial interest in the
securities. The Investor agrees not to sell, hypothecate
or otherwise transfer the Investor’s securities unless the
securities are registered under Federal and applicable state
securities laws or unless, in the opinion of counsel satisfactory
to the Company, an exemption from such laws is
available.
Section 3.5. Accredited Investor
. The Investor is an “ Accredited Investor
” as that term is defined in Rule 501(a)(3) of Regulation D
of the Securities Act.
Section 3.6. Information
. The Investor and its advisors (and its counsel), if
any, have been furnished with all materials relating to the
business, finances and operations of the Company and information it
deemed material to making an informed investment
decision. The Investor and its advisors, if any, have
been afforded the opportunity to ask questions of the Company and
its management. Neither such inquiries nor any other due
diligence investigations conducted by such Investor or its
advisors, if any, or its representatives shall modify, amend or
affect the Investor’s right to rely on the Company’s
representations and warranties contained in this
Agreement. The Investor understands that its investment
involves a high degree of risk. The Investor is in a
position regarding the Company, which, based upon employment,
family relationship or economic bargaining power, enabled and
enables such Investor to obtain information from the Company in
order to evaluate the merits and risks of this
investment. The Investor has sought such accounting,
legal and tax advice, as it has considered necessary to make an
informed investment decision with respect to this
transaction.
Section 3.7. Receipt of Documents .
The Investor and its counsel have received and read in their
entirety: (i) this Agreement and the Exhibits annexed
hereto; (ii) all due diligence and other information necessary to
verify the accuracy and completeness of such representations,
warranties and covenants; and (iii) answers to all questions the
Investor submitted to the Company regarding an investment in the
Company; and the Investor has relied on the information contained
therein and has not been furnished any other documents, literature,
memorandum or prospectus.
Section 3.8. Registration Rights
Agreement . The parties have entered into the
Registration Rights Agreement dated the date hereof.
Section 3.9. No General
Solicitation . Neither the Company, nor any of its
affiliates, nor any person acting on its or their behalf, has
engaged in any form of general solicitation or general advertising
(within the meaning of Regulation D under the Securities Act) in
connection with the offer or sale of the shares of Common Stock
offered hereby.
Section 3.10. Not an Affiliate
. The Investor is not an officer, director or a person
that directly, or indirectly through one or more intermediaries,
controls or is controlled by, or is under common control with the
Company or any “ Affiliate ” of the Company (as
that term is defined in Rule 405 of the Securities Act).
Section 3.11. Trading Activities
. The Investor’s trading activities with respect
to the Company’s Common Stock shall be in compliance with all
applicable federal and state securities laws, rules and regulations
and the rules and regulations of the Principal Market on which the
Company’s Common Stock is listed or traded and Investor will
comply with any requests that the SEC makes in connection with the
Filing of the Registration Agreement to ensure such compliance.
Neither the Investor nor its affiliates has an open short position
in the Common Stock of the Company, the Investor agrees that it
shall not, and that it will cause its affiliates not to, engage in
any short sales of or hedging transactions with respect to the
Common Stock, provided that the Company acknowledges and
agrees that upon receipt of an Drawdown Notice the Investor has the
right to sell the shares to be issued to the Investor pursuant to
the Drawdown Notice during the applicable Pricing
Period.
ARTICLE IV.
Representations and Warranties of
the Company
Except as stated below, on the disclosure
schedules attached hereto or in the SEC Documents (as defined
herein), the Company hereby represents and warrants to, and
covenants with, the Investor that the following are true and
correct as of the date hereof:
Section 4.1. Organization and
Qualification . The Company is duly incorporated or
organized and validly existing in the jurisdiction of its
incorporation or organization and has all requisite corporate power
to own its properties and to carry on its business as now being
conducted. Each of the Company and its subsidiaries is
duly qualified as a foreign corporation to do business and is in
good standing in every jurisdiction in which the nature of the
business conducted by it makes such qualification necessary, except
to the extent that the failure to be so qualified or be in good
standing would not have a Material Adverse Effect on the Company
and its subsidiaries taken as a whole.
Section 4.2. Authorization,
Enforcement, Compliance with Other Instruments . (i)
The Company has the requisite corporate power and authority to
enter into and perform this Agreement, the Registration Rights
Agreement, the Placement Agent Agreement and any related
agreements, in accordance with the terms hereof and thereof, (ii)
the execution and delivery of this Agreement, the Registration
Rights Agreement, the Placement Agent Agreement and any related
agreements by the Company and the consummation by it of the
transactions contemplated hereby and thereby, have been duly
authorized by the Company’s Board of Directors and no further
consent or authorization is required by the Company, its Board of
Directors or its stockholders, (iii) this Agreement, the
Registration Rights Agreement, the Placement Agent Agreement and
any related agreements have been duly executed and delivered by the
Company, (iv) this Agreement, the Registration Rights Agreement,
the Placement Agent Agreement and assuming the execution and
delivery thereof and acceptance by the Investor and any related
agreements constitute the valid and binding obligations of the
Company enforceable against the Company in accordance with their
terms, except as such enforceability may be limited by general
principles of equity or applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating
to, or affecting generally, the enforcement of creditors’
rights and remedies.
Section 4.3. Capitalization
. The authorized capital stock of the Company consists
of 450,000,000 shares of Common Stock, $0.001 par value per share
and 50,000,000 shares of Preferred Stock, (“ Preferred
Stock ”), of which approximately 13,370,270, shares of
Common Stock and no shares of Preferred Stock are issued and
outstanding. All of such outstanding shares have been
validly issued and are fully paid and
nonassessable. Except as disclosed in the SEC Documents,
no shares of Common Stock are subject to preemptive rights or any
other similar rights or any liens or encumbrances suffered or
permitted by the Company. Except as disclosed in the SEC
Documents, as of the date hereof, (i) there are no outstanding
options, warrants, scrip, rights to subscribe to, calls or
commitments of any character whatsoever relating to, or securities
or rights convertible into, any shares of capital stock of the
Company or any of its subsidiaries, or contracts, commitments,
understandings or arrangements by which the Company or any of its
subsidiaries is or may become bound to issue additional shares of
capital stock of the Company or any of its subsidiaries or options,
warrants, scrip, rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities or rights
convertible into, any shares of capital stock of the Company or any
of its subsidiaries, (ii) there are no outstanding debt securities
( iii) there are no outstanding registration statements
other than on Form S-1and (iv) there are no agreements or
arrangements under which the Company or any of its subsidiaries is
obligated to register the sale of any of their securities under the
Securities Act (except pursuant to the Registration Rights
Agreement). There are no securities or instruments
containing anti-dilution or similar provisions that will be
triggered by this Agreement or any related agreement or the
consummation of the transactions described herein or
therein. The Company has furnished to the Investor true
and correct copies of the Company’s Certificate of
Incorporation, as amended and as in effect on the date hereof (the
“ Certificate of Incorporation ”), and the
Company’s By-laws, as in effect on the date hereof (the
“ By-laws ”), and the terms of all securities
convertible into or exercisable for Common Stock and the material
rights of the holders thereof in respect thereto.
Section 4.4. No Conflict
. The execution, delivery and performance of this
Agreement by the Company and the consummation by the Company of the
transactions contemplated hereby will not (i) result in a violation
of the Certificate of Incorporation, any certificate of
designations of any outstanding series of preferred stock of the
Company or By-laws or (ii) conflict with or constitute a default
(or an event which with notice or lapse of time or both would
become a default) under, or give to others any rights of
termination, amendment, acceleration or cancellation of, any
agreement, indenture or instrument to which the Company or any of
its subsidiaries is a party, or result in a violation of any law,
rule, regulation, order, judgment or decree (including federal and
state securities laws and regulations and the rules and regulations
of the Principal Market on which the Common Stock is quoted)
applicable to the Company or any of its subsidiaries or by which
any material property or asset of the Company or any of its
subsidiaries is bound or affected and which would cause a Material
Adverse Effect. Except as disclosed in the SEC
Do